Home Applications 217901 Application 217901
Type NDA
Sponsor SATSUMA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ATZUMI DIHYDROERGOTAMINE MESYLATE POWDER;NASAL EQ 5.2MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217901-001 ATZUMI DIHYDROERGOTAMINE MESYLATE EQ 5.2MG BASE POWDER / NASAL RLD, RS 2025-04-30
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217901-001 12594273 2033-09-24 Drug product 2026-05-04 N217901-001 10792253 2037-08-04 Drug product 2025-05-23 N217901-001 11872314 2037-08-04 Drug product 2025-05-23 N217901-001 10758532 2039-12-11 Drug product 2025-05-23 N217901-001 12263162 2039-12-11 Drug product 2025-05-23 N217901-001 11744967 2041-10-12 Drug product 2025-05-23 N217901-001 12102754 2041-10-12 Drug product 2025-05-23
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217901-001 NP 2028-04-30
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217901-001 ATZUMI EQ 5.2MG BASE POWDER / NASAL RLD, RS 2025-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 ATZUMI EQ 5.2MG BASE POWDER / NASAL RLD, RS 2025-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217901-001 ATZUMI EQ 5.2MG BASE POWDER / NASAL RLD, RS 2025-04-30 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 ATZUMI EQ 5.2MG BASE POWDER / NASAL RLD, RS 2025-04-30 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217901-001 10792253 2037-08-04 Drug product 2025-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217901-001 11872314 2037-08-04 Drug product 2025-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217901-001 10758532 2039-12-11 Drug product 2025-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217901-001 12263162 2039-12-11 Drug product 2025-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217901-001 11744967 2041-10-12 Drug product 2025-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217901-001 12102754 2041-10-12 Drug product 2025-05-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 10792253 2037-08-04 Drug product 2025-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 11872314 2037-08-04 Drug product 2025-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 10758532 2039-12-11 Drug product 2025-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 12263162 2039-12-11 Drug product 2025-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 11744967 2041-10-12 Drug product 2025-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 12102754 2041-10-12 Drug product 2025-05-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217901-001 10792253 2037-08-04 Drug product 2025-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217901-001 11872314 2037-08-04 Drug product 2025-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217901-001 10758532 2039-12-11 Drug product 2025-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217901-001 12263162 2039-12-11 Drug product 2025-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217901-001 11744967 2041-10-12 Drug product 2025-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217901-001 12102754 2041-10-12 Drug product 2025-05-23 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 12594273 2033-09-24 Drug product 2026-05-04 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 10792253 2037-08-04 Drug product 2025-05-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 11872314 2037-08-04 Drug product 2025-05-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 10758532 2039-12-11 Drug product 2025-05-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 12263162 2039-12-11 Drug product 2025-05-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 11744967 2041-10-12 Drug product 2025-05-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 12102754 2041-10-12 Drug product 2025-05-23 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217901-001 NP 2028-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217901-001 NP 2028-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217901-001 NP 2028-04-30 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217901-001 NP 2028-04-30 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ATZUMI DIHYDROERGOTAMINE MESYLATE Satsuma Pharmaceuticals, Inc. 0982a44a-dc0c-75c0-e063-6394a90a6d6c 2026-06-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217901 application number: NDA217901
Documents# Document, Submission type, Date table Document Submission type Date 82149 ORIG 2025-05-05 82285 ORIG 2025-04-30 82284 ORIG 2025-04-30